Select Publications

Books

Darke S; Lappin J; Farrell M, 2021, The pocket guide to drugs and health, Silverback, London

Darke S; Lappin J; Farrell M, 2019, The Clinician's Guide to Illicit Drugs and Health, Silverback Publishing, Great Britain, https://www.silverbackpublishing.org/products/the-clinicians-guide-to-illicit-drugs-and-health

Book Chapters

Dazzan P; Morgan K; Lappin J; Fearon P, 2012, 'Neuroimaging and psychosis: Are brain changes in individuals with psychosis neurodevelopmental for some and progressive for others?', in Schizophrenia: The Final Frontier - A Festschrift for Robin M. Murray, pp. 147 - 154, http://dx.doi.org/10.4324/9780203808771

Laurens K; Hodgins S; Taylor EA; Murray RM, 2011, 'Is earlier intervention for schizophrenia possible? Identifying antecedents of schizophrenia in children aged 9-12 years', in David AS; Kapur S; McGuffin P (ed.), Schizophrenia: The Final Frontier - A Festschrift for Robin M. Murray, Psychology Press Ltd, Taylor & Francis Press, pp. 19 - 32, http://dx.doi.org/10.4324/9780203808771

Ebmeier KP; Lappin JM, 2002, 'Electromagnetic Stimulation and Affective Disorders<footref rid="foot01"><sup>1</sup></footref>', in Perspectives in Affective Disorders, KARGER, pp. 167 - 177, http://dx.doi.org/10.1159/000066883

Ebmeier KP; Lappin JM, 2001, 'Electromagnetic stimulation in psychiatry', in Advances in Psychiatric Treatment, edn. 3, pp. 181 - 188, http://dx.doi.org/10.1192/apt.7.3.181

Journal articles

Lappin JM; Zahra E; Darke S; Shand F; Sharma S; Draper B; Connors MH; Dear B; Titov N; Campbell G, 2022, 'Presentations to the emergency department with self-harm or suicidal behaviours: A role for digital mental health services?', Journal of Psychiatric Research, vol. 154, pp. 50 - 55, http://dx.doi.org/10.1016/j.jpsychires.2022.07.046

Cohn SL; Mohan A; Lappin JM; Curtis J; Scott JG, 2022, 'Anti-N-Methyl-d-Aspartate Receptor Antibody Testing in First-Episode Psychosis: Universal or Targeted Testing.', J Neuropsychiatry Clin Neurosci, pp. appineuropsych21080214, http://dx.doi.org/10.1176/appi.neuropsych.21080214

Lappin JM; Davies K; O'Donnell M; Walpola IC, 2022, 'Underuse of recommended treatments among people living with treatment-resistant psychosis', Frontiers in Psychiatry, vol. 13, http://dx.doi.org/10.3389/fpsyt.2022.987468

O'Dea D; Curtis J; Scully A; Lappin J, 2022, 'A pilot study of a mindfulness informed yoga intervention in young people with psychosis', Early Intervention in Psychiatry, vol. 16, pp. 1036 - 1042, http://dx.doi.org/10.1111/eip.13264

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2022, 'Characteristics of fatal tapentadol-related toxicity in Australia', Drug and Alcohol Review, vol. 41, pp. 1071 - 1077, http://dx.doi.org/10.1111/dar.13462

Darke S; Chrzanowska A; Campbell G; Zahra E; Lappin J, 2022, 'Barbiturate-related hospitalisations, drug treatment episodes, and deaths in Australia, 2000‒2018', Medical Journal of Australia, vol. 216, pp. 194 - 198, http://dx.doi.org/10.5694/mja2.51306

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ synthetic opioid toxicity in Australia', Drug and Alcohol Dependence, vol. 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109292

Lappin J, 2022, 'Clinical Management of Withdrawal Series', Addiction, vol. 117, pp. 517, http://dx.doi.org/10.1111/add.15708

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ benzodiazepine toxicity in Australia', Forensic Science International, vol. 331, pp. 111140, http://dx.doi.org/10.1016/j.forsciint.2021.111140

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2022, 'Characteristics of fatal gabapentinoid-related poisoning in Australia, 2000–2020', Clinical Toxicology, vol. 60, pp. 304 - 310, http://dx.doi.org/10.1080/15563650.2021.1965159

Darke S; Duflou J; Peacock A; Chrzanowska A; Farrell M; Lappin J, 2022, 'Clinical characteristics of fatal cocaine toxicity in Australia, 2000–2021', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13581

Lappin JM, 2022, 'Comorbid substance use in psychosis: Someone else’s problem?', Australian and New Zealand Journal of Psychiatry, vol. 56, pp. 5 - 7, http://dx.doi.org/10.1177/00048674211065669

Srasuebkul P; Walker AR; Cvejic RC; Trollor JN; Lappin JM; Curtis J; Samaras K; Dean K; Ward PB; Reppermund S, 2022, 'Hospital service utilisation of people previously hospitalised with different subtypes of psychotic disorder: A record linkage study', Australian and New Zealand Journal of Psychiatry, pp. 48674221115642, http://dx.doi.org/10.1177/00048674221115642

Darke S; Duflou J; Peacock A; Chrzanowska A; Farrell M; Lappin J, 2022, 'Rates, characteristics and toxicology of cocaine-related deaths in Australia, 2000–2021', Addiction, http://dx.doi.org/10.1111/add.16055

Talukder SR; Lappin JM; Boland V; McRobbie H; Courtney RJ, 2021, 'Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders', TOBACCO CONTROL, http://dx.doi.org/10.1136/tobaccocontrol-2021-056843

Darke S; Banister S; Farrell M; Duflou J; Lappin J, 2021, '‘Synthetic cannabis’: A dangerous misnomer', International Journal of Drug Policy, vol. 98, http://dx.doi.org/10.1016/j.drugpo.2021.103396

Campbell G; Darke S; Hall W; Lappin J, 2021, 'Increased barbiturate deaths: an unintended consequence of increased publicity for methods of do-it-yourself euthanasia?', Addiction, vol. 116, pp. 3273 - 3275, http://dx.doi.org/10.1111/add.15573

Wang TY; Fan TT; Lappin JM; Li XD; Zhao YM; Wu P; Shi J; Bao YP; Lu L, 2021, 'Cognitive improvement among abstinent methamphetamine users: A 2-year prospective longitudinal study', American Journal on Addictions, vol. 30, pp. 543 - 551, http://dx.doi.org/10.1111/ajad.13209

Lappin JM; Darke S, 2021, 'Methamphetamine and heightened risk for early-onset stroke and Parkinson's disease: A review', Experimental Neurology, vol. 343, pp. 113793, http://dx.doi.org/10.1016/j.expneurol.2021.113793

Cvejic RC; Srasuebkul P; Walker AR; Reppermund S; Lappin JM; Curtis J; Samaras K; Dean K; Ward P; Trollor JN, 2021, 'The health service contact patterns of people with psychotic and non-psychotic forms of severe mental illness in New South Wales, Australia: A record-linkage study', Australian and New Zealand Journal of Psychiatry, vol. 56, pp. 675 - 685, http://dx.doi.org/10.1177/00048674211031483

Wells R; Murad M; Higgins M; Smith L; Lenette C; Lappin J; Dew A; Boydell K; Bibby H; Cassaniti M; Isaacs D; Raman S; Zwi K, 2021, 'Exploring the intersection of human rights, health, disability and refugee status: An arts-based approach', Australian Journal of Human Rights, http://dx.doi.org/10.1080/1323238X.2021.1882044

Poon AWC; Lappin JM; Cassidy A; Breckenridge J, 2021, 'Scoping Review of Family Interventions That Support the Physical Health of Caregivers', Research on Social Work Practice, vol. 31, pp. 234 - 243, http://dx.doi.org/10.1177/1049731520974444

Campbell G; Darke S; Zahra E; Duflou J; Shand F; Lappin J, 2021, 'Trends and characteristics in barbiturate deaths Australia 2000-2019: a national retrospective study', Clinical toxicology (Philadelphia, Pa.), vol. 59, pp. 224 - 230, http://dx.doi.org/10.1080/15563650.2020.1789653

Darke S; Duflou J; Farrell M; Peacock A; Lappin J, 2021, 'Characteristics and circumstances of death related to the self-administration of ketamine', Addiction, vol. 116, pp. 339 - 345, http://dx.doi.org/10.1111/add.15154

Yang R; Curtis J; Jensen C; Levy P; Chown K; Lappin JM, 2021, 'Detection and intervention in emerging youth mental health issues: Outcomes from the first year of the CASPAR service', Early Intervention in Psychiatry, vol. 15, pp. 167 - 173, http://dx.doi.org/10.1111/eip.12956

Ferruccio NP; Tosato S; Lappin JM; Heslin M; Donoghue K; Giordano A; Lomas B; Reininghaus U; Onyejiaka A; Chan RCK; Croudace T; Jones PB; Murray RM; Fearon P; Doody GA; Morgan C; Dazzan P, 2021, 'Neurological Signs at the First Psychotic Episode as Correlates of Long-Term Outcome: Results From the AESOP-10 Study', Schizophrenia bulletin, vol. 47, pp. 118 - 127, http://dx.doi.org/10.1093/schbul/sbaa089

Darke S; Duflou J; Larance B; Farrell M; Lappin J, 2021, 'Characteristics and circumstances of death related to buprenorphine toxicity in Australia', Drug and Alcohol Dependence, vol. 218, http://dx.doi.org/10.1016/j.drugalcdep.2020.108360

Gale-Grant O; Dazzan P; Lappin JM; Donoghue K; Reininghaus U; Croudace T; Jones PB; Murray RM; Fearon P; Doody GA; Morgan C; Heslin M, 2021, 'Diagnostic stability and outcome after first episode psychosis', Journal of Mental Health, vol. 30, pp. 104 - 112, http://dx.doi.org/10.1080/09638237.2020.1818191

Morgan C; Dazzan P; Lappin J; Heslin M; Donoghue K; Fearon P; Jones PB; Murray RM; Doody GA; Reininghaus U, 2021, 'Rethinking the course of psychotic disorders: Modelling long-Term symptom trajectories', Psychological Medicine, pp. 1 - 10, http://dx.doi.org/10.1017/S0033291720004705

Dew A; Lenette C; Smith L; Boydell K; Bibby H; Lappin J; Coello M; Raman S; Velkou K; Wells R; Momartin S; Blunden H; Higgins M; Murad M; Barry J; Mohammad Y, 2020, '“To the Arabic community disability is not normal”: Understandings of disability among Iraqi and Syrian people from refugee backgrounds.', Journal of Refugee Studies, http://dx.doi.org/10.1093/jrs/feaa111

Wang Y; Liu M; Lu Q; Farrell M; Lappin JM; Shi J; Lu L; Bao Y, 2020, 'Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis', Neurology, vol. 95, pp. E2610 - E2621, http://dx.doi.org/10.1212/WNL.0000000000010752

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2020, 'Characteristics and circumstances of death related to gamma hydroxybutyrate (GHB)', Clinical Toxicology, vol. 58, pp. 1028 - 1033, http://dx.doi.org/10.1080/15563650.2020.1726378

Lappin JM, 2020, 'Long-term opioid use Assessment of mental health issues', Medicine Today, vol. 21, pp. 48 - 51

Campbell G; Darke S; Degenhardt L; Townsend H; Carter G; Draper B; Farrell M; Duflou J; Lappin J, 2020, 'Prevalence and Characteristics Associated with Chronic Noncancer Pain in Suicide Decedents: A National Study', Suicide and Life-Threatening Behavior, vol. 50, pp. 778 - 791, http://dx.doi.org/10.1111/sltb.12627

Boydell K; Bennett J; Dew A; Lappin J; Lenette C; Ussher J; Vaughan P; Wells R, 2020, 'Women and Stigma: A Protocol for Understanding Intersections of Experience through Body Mapping', International Journal of Environmental Research and Public Health, vol. 17, pp. 5432 - 5432, http://dx.doi.org/10.3390/ijerph17155432

Wang YH; Li JQ; Shi JF; Que JY; Liu JJ; Lappin JM; Leung J; Ravindran AV; Chen WQ; Qiao YL; Shi J; Lu L; Bao YP, 2020, 'Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies', Molecular Psychiatry, vol. 25, pp. 1487 - 1499, http://dx.doi.org/10.1038/s41380-019-0595-x

Dazzan P; Lappin JM; Heslin M; Donoghue K; Lomas B; Reininghaus U; Onyejiaka A; Croudace T; Jones PB; Murray RM; Fearon P; Doody GA; Morgan C, 2020, 'Symptom remission at 12-weeks strongly predicts long-term recovery from the first episode of psychosis', Psychological Medicine, vol. 50, pp. 1452 - 1462, http://dx.doi.org/10.1017/S0033291719001399

Darke S; Duflou J; Farrell M; Peacock A; Lappin J, 2020, 'Characteristics and circumstances of synthetic cannabinoid-related death', Clinical Toxicology, vol. 58, pp. 368 - 374, http://dx.doi.org/10.1080/15563650.2019.1647344

Lappin JM; Thomas D; Curtis J; Blowfield S; Gatsi M; Marr G; Courtney R, 2020, 'Targeted intervention to reduce smoking among people with severe mental illness: Implementation of a smoking cessation intervention in an inpatient mental health setting', Medicina (Lithuania), vol. 56, http://dx.doi.org/10.3390/medicina56040204

Roxburgh A; Lappin J, 2020, 'MDMA-related deaths in Australia 2000 to 2018', International Journal of Drug Policy, vol. 76, pp. 102630, http://dx.doi.org/10.1016/j.drugpo.2019.102630

Teasdale SB; Morell R; Lappin JM; Curtis J; Watkins A; Ward PB, 2020, 'Prevalence and correlates of food insecurity in community-based individuals with severe mental illness receiving long-acting injectable antipsychotic treatment', British Journal of Nutrition, vol. 124, pp. 470 - 477, http://dx.doi.org/10.1017/S0007114520001191

Lappin JM, 2019, 'Commentary on Petersen et al. (2019): Development of problematic substance use in the years that follow diagnosis of schizophrenia', Addiction, vol. 114, pp. 2227 - 2228, http://dx.doi.org/10.1111/add.14791

Morell R; Curtis J; Watkins A; Poole J; Fibbins H; Rossimel E; Gerrard M; White A; Teasdale S; Ward PB; Lappin J, 2019, 'Cardio-metabolic risk in individuals prescribed long-acting injectable antipsychotic medication', Psychiatry Research, vol. 281, http://dx.doi.org/10.1016/j.psychres.2019.112606

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2019, 'Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in Australia', Drug and Alcohol Dependence, vol. 204, pp. 107556, http://dx.doi.org/10.1016/j.drugalcdep.2019.107556


Back to profile page